Dexcom (DXCM) Income from Continuing Operations (2010 - 2026)

Dexcom (DXCM) has 17 years of Income from Continuing Operations data on file, last reported at 199500000.0 in Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 199500000.0, up 89.28% year-over-year; the trailing twelve-month figure through Mar 2026 was 930400000.0 (up 73.84% YoY), and the FY2025 annual result was 836300000.0, up 45.14% from the prior year.
• Income from Continuing Operations slipped to 199500000.0 in Q1 2026 per DXCM's latest filing, from 267300000.0 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 283800000.0 in Q3 2025 and troughed at 48600000.0 in Q1 2023.
• A 5-year average of 146747058.82 and a median of 134600000.0 in 2024 frame the typical range for Income from Continuing Operations.
• The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations jumped 1832.08% in 2022, then slumped 50.05% in 2023.
• A 5-year view of Income from Continuing Operations shows it stood at 91800000.0 in 2022, then surged by 179.19% to 256300000.0 in 2023, then slumped by 40.81% to 151700000.0 in 2024, then jumped by 76.2% to 267300000.0 in 2025, then retreated by 25.36% to 199500000.0 in 2026.
• Business Quant data shows DXCM's Income from Continuing Operations at 199500000.0 in Q1 2026, 267300000.0 in Q4 2025, and 283800000.0 in Q3 2025.